Too much and not enough: revisiting maintenance rituximab in indolent lymphomas. | Haematologica;107(2): 353-354, 2022 02 01. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

WHO COVID-19 Research Database

News/Update/Help

Advanced Search

The WHO Covid-19 Research Database is a resource created in response to the Public Health Emergency of International Concern (PHEIC). Its content remains searchable and spans the time period March 2020 to June 2023. Since June 2023, manual updates to the database have been discontinued.

Too much and not enough: revisiting maintenance rituximab in indolent lymphomas.

Smith, Sonali.

Smith S; MD FASCO Elwood V. Jensen Professor of Medicine Chief, Section of Hematology/Oncology Co-Leader, Cancer Service Line Co-Director, Lymphoma Program The University of Chicago 5841 S. Maryland Avenue MC2115 Chicago, IL 60637. smsmith@medicine.bsd.uchicago.edu.

Haematologica ; 107(2): 353-354, 2022 02 01.

Article in English | MEDLINE | ID: covidwho-1725345

Subject(s)

Lymphoma, Follicular; Lymphoma, Non-Hodgkin; Humans; Rituximab/therapeutic use

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Lymphoma, Non-Hodgkin / Lymphoma, Follicular Limits: Humans Language: English Journal: Haematologica Year: 2022 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Lymphoma, Non-Hodgkin / Lymphoma, Follicular Limits: Humans Language: English Journal: Haematologica Year: 2022 Document Type: Article